Today: 25 April 2026

Arista Networks Stock Today (ANET), November 23, 2025: AI Networking Leader Pulls Back, But Wall Street Still Sees Upside

Arista Networks Stock Today (ANET), November 23, 2025: AI Networking Leader Pulls Back, But Wall Street Still Sees Upside

Arista Networks shares closed at $117.43 on Friday, down 1.81% for the day and 25.5% so far in November. Trading volume surged to 16.5 million shares, about 65% above average. The stock has dropped despite strong Q3 results and raised guidance, as investors reacted to management’s more cautious growth outlook. Arista’s market cap stands near $148 billion.
23 November 2025
DroneShield (ASX:DRO): 10 Things to Know Before the ASX Opens on 24 November 2025

DroneShield (ASX:DRO): 10 Things to Know Before the ASX Opens on 24 November 2025

DroneShield shares closed at A$1.71–A$1.72 on Friday, down 9% for the day and 26% for the week, with the price now 75% below its October peak. The company lost about A$4.3 billion in market value after a contract disclosure error triggered an ASX compliance probe. Market cap stands near A$1.5 billion. Trading was briefly paused as the company corrected its announcement.
23 November 2025
BP Stock Today, November 23, 2025: Price, Dividend Yield and Outlook After Q3 Earnings Beat

BP Stock Today, November 23, 2025: Price, Dividend Yield and Outlook After Q3 Earnings Beat

BP shares closed at $35.98 in New York on November 21, near a 52-week high after third-quarter earnings beat forecasts and the company raised its dividend and buybacks. Market cap stands at about $91 billion. Investors are watching BP’s renewed focus on oil and gas, new projects, and operational risks, including a recent U.S. pipeline leak.
Carvana Stock (CVNA) Today, November 23, 2025: Deutsche Bank Initiation, Big 13F Moves and Q3 Momentum

Carvana Stock (CVNA) Today, November 23, 2025: Deutsche Bank Initiation, Big 13F Moves and Q3 Momentum

Carvana closed Friday at about $310 per share, valuing the company near $68 billion with a P/E ratio close to 71 and a beta of 3.5. Deutsche Bank initiated coverage with a “Buy” rating and a $395 target. Handelsbanken Fonder AB trimmed its stake by 5%, while Ensign Peak Advisors and Cetera Investment Advisers increased their holdings by 4.1% and 17.9%, respectively.
23 November 2025
Cloudflare Stock Today, November 23, 2025 (NET): Institutional Moves, Outage Fallout and the AI Story Behind the Volatility

Cloudflare Stock Today, November 23, 2025 (NET): Institutional Moves, Outage Fallout and the AI Story Behind the Volatility

Cloudflare shares opened Friday at $186.56, closing the week down sharply from early November highs near $260 after an internet outage and insider selling. The stock is up about 80% in 2025 but trades well below its 50- and 200-day averages. American Century trimmed its stake by 2% in Q2, while Bank Julius Baer cut holdings by 25.6%. Institutions control about 83% of Cloudflare’s float.
Walgreens Boots Alliance Stock Today (November 23, 2025): What the Sycamore Buyout Means for Former WBA Shareholders

Walgreens Boots Alliance Stock Today (November 23, 2025): What the Sycamore Buyout Means for Former WBA Shareholders

Walgreens Boots Alliance was acquired by Sycamore Partners and delisted from Nasdaq on August 28, 2025. Shareholders received $11.45 in cash per share and a contingent right tied to Walgreens’ VillageMD stake, with a maximum potential value of $3.00 per share. WBA stock is no longer traded. Any current quote is historical only.
Citigroup Stock Today (C): Price, Data‑Breach Fears, New CFO Shake‑Up and Q3 Momentum – November 23, 2025

Citigroup Stock Today (C): Price, Data‑Breach Fears, New CFO Shake‑Up and Q3 Momentum – November 23, 2025

Citigroup closed Friday at $98.70, up 1.1%, with shares up about 40–45% over the past year. A November 12 cyberattack on vendor SitusAMC may have exposed Citi client data, though the bank’s core systems were not affected. New filings show Journey Strategic Wealth and Neo Ivy Capital raised stakes in Citigroup, while Rhumbline Advisers trimmed its position. The next dividend payment is due November 26.
23 November 2025
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics dissolved and began liquidation after filing a Certificate of Dissolution on June 26, 2024. Nasdaq delisted NBSE in May 2024; trading was suspended and shares are no longer listed on any exchange. Shareholders received $0.13 per share and a non-tradable escrow share for potential future payouts. No active market exists, despite some data vendors still showing outdated prices.
23 November 2025
Zoom Communications (ZM) Stock Today, November 23, 2025: AI Pivot Faces a Big Earnings Test

Zoom Communications (ZM) Stock Today, November 23, 2025: AI Pivot Faces a Big Earnings Test

Zoom closed at $78.63 on November 21, with after-hours trading near $79, valuing the company at about $23.5 billion. Q2 FY 2026 revenue rose 4.7% to $1.22 billion, with non-GAAP operating margins above 40%. Shares remain over 80% below 2020 highs. Q3 results are due November 24; management expects $1.21 billion in revenue and EPS of $1.42–$1.44.
Opendoor Technologies (OPEN) Stock Today: Hedge Fund Stake, Warrant Dividend and Valuation Jitters – November 23, 2025

Opendoor Technologies (OPEN) Stock Today: Hedge Fund Stake, Warrant Dividend and Valuation Jitters – November 23, 2025

Opendoor Technologies shares jumped 9.58% Friday to $6.75 after hedge fund D.E. Shaw disclosed a 6.4% stake. The stock has surged over 325% in 2025, swinging from a 52-week low of $0.51 to nearly $10.87. Most of D.E. Shaw’s position is held in a short-term trading fund. Analysts flag the move as tactical, with concerns the stock is outpacing fundamentals.
23 November 2025
CSL Limited (ASX:CSL): What You Need to Know Before the Market Opens on 24 November 2025

CSL Limited (ASX:CSL): What You Need to Know Before the Market Opens on 24 November 2025

CSL shares closed at A$178.85 on Friday, down about 36% year to date after profit downgrades and restructuring. The company is cutting 3,000 jobs, closing 22 US plasma centers, and has launched a US$1.5 billion US expansion and an on-market buy-back. Revenue and profit growth guidance for FY26 have been lowered. CSL has repurchased over 2 million shares as of 19 November.
23 November 2025
Commonwealth Bank of Australia (ASX: CBA) Share Price – What to Know Before Market Open on 24 November 2025

Commonwealth Bank of Australia (ASX: CBA) Share Price – What to Know Before Market Open on 24 November 2025

Commonwealth Bank of Australia shares closed at $153.06 on Friday, down nearly 5% after its first-quarter update showed rising costs and a lower net interest margin. The stock is now about 20% below its 52-week high, despite being 30% higher than a year ago. CBA remains the largest weight in the ASX 200, with a market cap near $256 billion.
23 November 2025
Macquarie Group (ASX: MQG) Stock – What to Know Before the ASX Opens on 24 November 2025

Macquarie Group (ASX: MQG) Stock – What to Know Before the ASX Opens on 24 November 2025

Macquarie Group closed at A$194.09 on Friday, down 0.22% for the day and about 12% lower year-to-date. First-half net profit rose 3% to A$1.655 billion but missed analyst forecasts by 11%. The company declared a A$2.80 interim dividend and extended its buyback, with over A$1 billion already spent. Macquarie faces regulatory scrutiny, compensation payouts, and pressure on its commodities business.
23 November 2025
AbbVie Stock Today (ABBV): Near Record Highs on New Cancer Approval, Raised Guidance and Dividend Hike – November 23, 2025

AbbVie Stock Today (ABBV): Near Record Highs on New Cancer Approval, Raised Guidance and Dividend Hike – November 23, 2025

AbbVie closed at $236.28 on November 21, 2025, near its 52-week high and up about 31% year to date. Q3 revenue rose 9.1% to $15.8 billion, led by immunology and neuroscience, while GAAP EPS dropped sharply due to a $2.7 billion R&D charge. The FDA granted full approval for EPKINLY in follicular lymphoma on November 18. AbbVie raised its 2025 revenue and EPS guidance and approved a 5.5% dividend hike for 2026.
23 November 2025
JetBlue (JBLU) Stock Today, November 23, 2025: Price, Q3 Earnings, New Europe Routes and What’s Next for the Airline

JetBlue (JBLU) Stock Today, November 23, 2025: Price, Q3 Earnings, New Europe Routes and What’s Next for the Airline

JetBlue shares closed Friday at $4.19, near the bottom of their 52-week range and about half their yearly high. The airline remains unprofitable but reported a narrower Q3 loss and higher revenue, aided by cost cuts and premium demand. New Boston–Barcelona and Boston–Milan routes are set for 2026. Short interest stands at roughly 18–22% of float.
Upstart Stock Today (UPST): Price, Outlook and the Impact of the New $1.5B Castlelake Deal – November 23, 2025

Upstart Stock Today (UPST): Price, Outlook and the Impact of the New $1.5B Castlelake Deal – November 23, 2025

Upstart Holdings closed Friday at $37.09, up 4.2% but near its 52-week low after a volatile month. Shares have dropped 26% in November and 39% year to date, despite Q3 revenue rising 71% to $277 million and EPS beating estimates. Management’s Q4 revenue guidance missed Wall Street targets, triggering a 15% after-hours drop. A new $1.5 billion loan agreement with Castlelake was announced.
23 November 2025
Tonix Pharmaceuticals Stock on November 23, 2025: Tonmya Launch, Bigger Buyback, and a $400M ATM Shape the TNXP Trade

Tonix Pharmaceuticals Stock on November 23, 2025: Tonmya Launch, Bigger Buyback, and a $400M ATM Shape the TNXP Trade

Tonix Pharmaceuticals’ first commercial fibromyalgia drug, Tonmya, is now available in U.S. pharmacies following FDA approval in August. TNXP shares closed Friday at $16.10, up 2.94%, but remain down about 51% for 2025. Market cap stands near $141 million, with negative net margins and a price-to-sales ratio of 13.7. Expanded share repurchase and ATM equity programs are in place.

Stock Market Today

  • Hanmi Financial's Fair Value Targets Adjust Amid Mixed Analyst Sentiment
    April 25, 2026, 6:36 AM EDT. Hanmi Financial's fair value estimate edged up from US$31.00 to US$32.13, reflecting mixed analyst views. Keefe Bruyette lifted its price target by US$0.50, signaling confidence in execution and balance sheet progress. Conversely, Piper Sandler cut its target by US$2, citing concerns over growth and profitability forecasts. The bank completed a buyback of 2.84% shares under its 2024 plan and increased buyback authorization to 2.3 million shares. Q1 2026 dividend rose 4% to US$0.28 per share. Key financial assumptions include revenue growth rising to 11.76%, net profit margin improving to 32.01%, and a lowered future price-to-earnings multiple of 9.32x. The evolving analyst tug of war highlights uncertainty in Hanmi Financial's valuation amid ongoing operational shifts.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 25.04.2026

25 April 2026
LIVEMarkets rolling coverageStarted: April 25, 2026, 12:00 AM EDTUpdated: April 25, 2026, 6:36 AM EDT Hanmi Financial's Fair Value Targets Adjust Amid Mixed Analyst Sentiment April 25, 2026, 6:36 AM EDT. Hanmi Financial's fair value estimate edged up from US$31.00 to US$32.13, reflecting mixed analyst views. Keefe Bruyette lifted its price target by US$0.50, signaling confidence in execution and balance sheet progress. Conversely, Piper Sandler cut its target by US$2, citing concerns over growth and profitability forecasts. The bank completed a buyback of 2.84% shares under its 2024 plan and increased buyback authorization to 2.3 million shares. Q1 2026 dividend
LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

25 April 2026
LightPath Technologies shares closed up 10.05% at $16.09 in Orlando Friday, after hitting $16.53 and surpassing recent analyst targets. Trading volume jumped to 6.35 million shares. The company reported a $97.8 million backlog and second-quarter revenue of $16.4 million, up 120% from a year earlier. Recent orders and investor focus center on defense optics and infrared camera systems.
Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

25 April 2026
Wolfspeed shares surged 13.36% to $31.23 on Friday, with trading volume hitting 8.4 million shares ahead of its May 5 earnings report. The chipmaker recently cut its debt by about $97 million and lowered annual interest expense by $62 million after refinancing in March. Wolfspeed reported a $151 million net loss last quarter and expects negative gross margins to continue.
Go toTop